Name File Type Size Last Modified
NNDSS_-_Table_I._infrequently_reported_notifiable_diseases.csv text/csv 276.2 KB 01/13/2026 01:51:PM
NNDSS_-_Table_I._infrequently_reported_notifiable_diseases.pdf application/pdf 379.2 KB 01/12/2026 09:03:AM

Project Citation: 

United States Department of Health and Human Services. Centers for Disease Control and Prevention, and NNDSS. NNDSS - Table I. infrequently reported notifiable diseases. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2026-01-13. https://doi.org/10.3886/E243996V1

Project Description

Project Title:  View help for Project Title NNDSS - Table I. infrequently reported notifiable diseases
Summary:  View help for Summary NNDSS - Table I. infrequently reported notifiable diseases - 2016. In this Table, provisional* cases of selected† infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) are displayed. Note: These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. Case counts in these tables are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. “Symbols and footnotes changed in week #4, please refer to the MMWR publication for the symbols/footnotes for weeks 1, 2, and 3”. Footnote: -: No reported cases N: Not reportable NA: Not available NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts. * Case counts for reporting year 2016 are provisional and subject to change. Data for years 2011 through 2015 are finalized. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. † This table does not include cases from the U.S. territories. Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions. § Calculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preceding years. Additional information is available at http://wwwn.cdc.gov/nndss/document/5yearweeklyaverage.pdf. ¶ Includes both neuroinvasive and nonneuroinvasive. Updated weekly reports from the Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases (ArboNET Surveillance). Data for West Nile virus are available in Table II. ** Not reportable in all reporting jurisdictions. Data from states where the condition is not reportable are excluded from this table, except for the arboviral diseases and influenza-associated pediatric mortality. Reporting exceptions are available at http://wwwn.cdc.gov/nndss/downloads.html. †† Office of Management and Budget approval of the NNDSS Revision #0920-0728 on January 21, 2016, authorized CDC to receive data for these conditions. CDC is in the process of soliciting data for these conditions (except Zika virus, congenital infection). CDC and the U.S. states are still modifying the technical infrastructure needed to collect and transmit data for Zika virus congenital infections. §§ Jamestown Canyon virus and Lacrosse virus have replaced California serogroup diseases. ¶¶ Data for Haemophilus influenzae (all ages, all serotypes) are available in Table II. *** Please refer to the MMWR publication for weekly updates to the footnote for this condition. ††† Please refer to the MMWR publication for weekly updates to the footnote for this condition. §§§ Data for meningococcal disease (all serogroups) are available in Table II. ¶¶¶ Please refer to the MMWR publication for weekly updates to the footnote for this condition. **** Updated weekly from reports to the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. †††† Please refer to the MMWR publication for weekly updates to the footnote for this condition. §§§§ All cases reported have occurred in travelers returning from affected areas, with their sexual contacts, or infants infected in utero. Read less
Original Distribution URL:  View help for Original Distribution URL https://data.cdc.gov/NNDSS/NNDSS-Table-I-infrequently-reported-notifiable-dis/dwqk-w36f/about_data

Scope of Project

Subject Terms:  View help for Subject Terms 2016; mmwr; nndss; wonder; nedss; netss; anthrax; arboviral diseases; chikungunya virus disease; eastern equine encephalitis virus disease; jamestown canyon virus; la crosse virus; powassan virus disease; st. louis encephalitis virus disease; western equine encephalitis virus disease; botulism; brucellosis; chancroid; cholera; cyclosporiasis; diphtheria; haemophilus influenzae invasive; hansen disease; hantavirus infection; hantavirus pulmonary syndrome; hemolytic uremic syndrome; postdiarrheal; hepatitis b infection perinatal; influenza-associated pediatric mortality; leptospirosis; listeriosis; measles; meningococcal disease invasive; novel influenza a; plague; poliomyelitis paralytic; polio virus infection nonparalytic; psittacosis; q fever; rabies human; sars-cov; smallpox; streptococcal toxic-shock syndrome; syphilis congenital; toxic-shock syndrome (staphylococcal); trichinellosis; tularemia; typhoid fever; vancomycin; viral hemorrhagic fever; crimean-congo; ebola; guanarito; junin; lassa fever; lujo virus; machupo; marburg fever; sabia-associated; yellow fever
Collection Notes:  View help for Collection Notes (Downloaded 1/12/2026)


Related Publications

Published Versions

Export Metadata

Report a Problem

Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.

This material is distributed exactly as received from the data depositor. ICPSR has not reviewed, checked, or processed this material. For additional information about the study, please contact the investigator(s) directly. If you have questions about the accessibility of materials distributed by ICPSR or require further assistance, please visit ICPSR's Accessibility Center.